B

Biohit Oyj
OMXH:BIOBV

Watchlist Manager
Biohit Oyj
OMXH:BIOBV
Watchlist
Price: 3.28 EUR -1.2%
Market Cap: €49.6m

Wall Street
Price Targets

BIOBV Price Targets Summary
Biohit Oyj

Wall Street analysts forecast BIOBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOBV is 3.77 EUR with a low forecast of 3.74 EUR and a high forecast of 3.89 EUR.

Lowest
Price Target
3.74 EUR
14% Upside
Average
Price Target
3.77 EUR
15% Upside
Highest
Price Target
3.89 EUR
18% Upside
Biohit Oyj Competitors:
Price Targets
CMTG
Claros Mortgage Trust Inc
21% Upside
VIB3
Villeroy & Boch AG
48% Upside
TEL
TE Connectivity Ltd
23% Upside
ENTX
Entera Bio Ltd
537% Upside

Revenue
Forecast

16% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
16% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Biohit Oyj's revenue is 16%. The projected CAGR for the next 4 years is 15%.

Operating Income
Forecast

N/A
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of Biohit Oyj's operating income for the next 4 years is 14%.

Net Income
Forecast

-19% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-19% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Biohit Oyj's net income is -19%. The projected CAGR for the next 4 years is 9%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOBV's stock price target?
Price Target
3.77 EUR

According to Wall Street analysts, the average 1-year price target for BIOBV is 3.77 EUR with a low forecast of 3.74 EUR and a high forecast of 3.89 EUR.

What is Biohit Oyj's Revenue forecast?
Projected CAGR
15%

For the last 13 years the compound annual growth rate for Biohit Oyj's revenue is 16%. The projected CAGR for the next 4 years is 15%.

What is Biohit Oyj's Operating Income forecast?
Projected CAGR
14%

The compound annual growth rate of Biohit Oyj's operating income for the next 4 years is 14%.

What is Biohit Oyj's Net Income forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Biohit Oyj's net income is -19%. The projected CAGR for the next 4 years is 9%.

Back to Top